B6.129P2-Dlg1tm1.1Abrie/Orl

Status

Available to order

EMMA IDEM:12717
Citation informationRRID:IMSR_EM:12717 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129P2-Dlg1tm1.1Abrie/Orl
Alternative nameDlg1tm1.1Abrie
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolDlg1tm1.1Abrie
Gene/Transgene symbolDlg1

Information from provider

ProviderHugues Abriel
Provider affiliationIBMM
Genetic informationDlg1 (SAP97) gene is dispersed over 26 exons (25 coding) in a genomic region of 110 kbp on chromosome 16. Dlg proteins are involved in cell proliferation, synapse formation and function, and epithelial cell polarity. The phenotype of a constitutive SAP97 gene trap mutant includes craniofacial abnormalities, neonatal lethality, and a number of malformations predominantly in the kidney and in the eye (Caruana, G. and Bernstein, A. (2001), Mol Cell Biol 21(5):1475-83; Naim, E. et al. (2005), Kidney Int 68(3):955-65; Nguyen, M.M. et al. (2003), Mol Cell Biol 23(24):8970-81). We aimed at deleting SAP97 in somatic cells upon induction in the heart using a cre recomb.-expressing specific mouse line, so we flanked SAP97 exons 1-3, including 900 bp of the upstream sequence, with loxP sites. Analysing the upstream region of SAP97 we identified a strong TATA box consensus preceded by a T-rich stretch about 130 bp upstream of the putative exon 1 (as there are, to our knowledge, no promoter studies, the exact transcription start site has not been mapped). Deletion of the loxP flanked region should therefore lead to the loss of the putative core promoter and the first three exons of SAP97 resulting in the loss of SAP97.
Phenotypic informationHomozygous:
No phenotype

Heterozygous:
No phenotype
Breeding historyMice were bred to obtain a floxed homozygous genotype and then more than 10 backcrosses to C57BL/6J. At least once every 1-2 years a new step of backcrossing has been done to refresh the line.
References
  • Cardiac-specific ablation of synapse-associated protein SAP97 in mice decreases potassium currents but not sodium current.;Gillet Ludovic, Rougier Jean-Sébastien, Shy Diana, Sonntag Stephan, Mougenot Nathalie, Essers Maria, Shmerling Doron, Balse Elise, Hatem Stéphane N, Abriel Hugues, ;2015;Heart rhythm;12;181-92; 25447080
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivinghomozygous C57BL/6J males

Literature references

  • Cardiac-specific ablation of synapse-associated protein SAP97 in mice decreases potassium currents but not sodium current.;Gillet Ludovic, Rougier Jean-Sébastien, Shy Diana, Sonntag Stephan, Mougenot Nathalie, Essers Maria, Shmerling Doron, Balse Elise, Hatem Stéphane N, Abriel Hugues, ;2015;Heart rhythm;12;181-92; 25447080

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).